Sea Crest Wealth Management, LLC Viking Therapeutics, Inc. Transaction History
Sea Crest Wealth Management, LLC
- $916 Million
- Q4 2024
A detailed history of Sea Crest Wealth Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 6,400 shares of VKTX stock, worth $208,384. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,400
Previous 7,190
10.99%
Holding current value
$208,384
Previous $455,000
43.52%
% of portfolio
0.03%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding VKTX
# of Institutions
478Shares Held
64.7MCall Options Held
5.76MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$196 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$152 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$68.9 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$61 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.5B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...